Dr. Vijay R. Patel, MD

Dr. Patel practices at Raritan Bay Primary Care & Cardiology Associates, PA in Matawan, New Jersey.

Dr. Patel's NPI, 1922045590, was assigned on June 1, 2006. Dr. Patel holds New Jersey license 25MA07517100.

Dr. Patel's primary practice is Raritan Bay Primary Care & Cardiology Associates, PA, at 246 State Highway 34, Matawan, NJ 07747 in Monmouth County. The practice phone is (732) 952-3800.

Dr. Patel's primary practice is Raritan Bay Primary Care & Cardiology Associates, PA in Matawan, New Jersey. Dr. Patel is also affiliated with Raritan Bay Medical Center. The medical group on file is Raritan Bay Primary Care & Cardiology Associates, PA. Dmand AI also links Dr. Patel to 2 more home health agencies, 1 physician office, 1 group practice or clinic and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Patel practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Patel's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Patel is licensed in New Jersey.

CMS data shows 8,217 Medicare services from Dr. Patel across 45 procedure codes in 2024, for 185 Medicare patients. Medicare paid $335,988 for them.

CMS counts 185 Medicare patients who saw Dr. Patel in 2024. The largest group is 65 to 74, with 72 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 75% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Patel's median patient age at 62, with 58% women.

In 2024, Dr. Patel wrote 17,366 Medicare Part D claims for 522 patients. 82% of them were for generic drugs. CMS names the drug for 16,502 of them, across 162 drugs with 11 or more claims each, at $2,269,098 in total drug cost. In 2023, CMS named 16,261 claims across 183 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Patel for performance year 2024, reported through an alternative payment model (APM). Dr. Patel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 11 procedures of removal of tissue by Dr. Patel, more than 62% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Patel, published from 2022 to 2025. 2022 was the busiest year, with 2. The most frequent topics are COVID-19, SARS-CoV-2 and Pandemics. Dr. Patel has published most often in Int J Cancer.

CMS Open Payments shows 293 general payments to Dr. Patel from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. AstraZeneca Pharmaceuticals LP paid the most, $833. It also lists 2 research payments totaling $70,410 from 2021 to 2022.